BioNews offers the next generation, “inbound” marketing approach to promoting and raising awareness for your company’s clinical trial, driving rare disease patient referrals through our incredibly niche rare disease digital platform.

Power your company’s clinical trial recruitment efforts through our network of disease-specific websites and social media, bringing together daily, optimized news content and vigorous social media activity and search engine exposure. This truly multi-channel, multi-content approach leverages niche marketing practices to ensure that only people who have an interest in the rare disease your company is focused on are exposed to your trail and messaging.

Our Clinical Trial Recruitment Process at a Glance:

  • Access to hard-to-reach rare disease patient populations & user groups.
  • Inbound marketing approach for high conversion rates.
  • Social media promotion of content for viral yet targeted promotion.
  • Search engine-driven clinical trial recruitment leads.
  • Valuable patient and user data for launching optimized campaigns.
The unique user data on many of our rare disease sites indicate that we reach 100% of rare disease patient populations.
Our user communities are highly engaged, with a majority visiting the site 3-5 times per week.
Research into our user base reveals that 90%+ of our readers identify as patients or caregivers.
96% of readers indicate that they trust the accuracy, independence, and authority our rare disease content.
Our rare disease platforms are multi-channel, multi-content ecospheres that engage rare disease communities via e-mail, web content, and social media.


For more information on our marketing services, contact [email protected], or fill out the form below.